Beijing Tiantan Biological Products Corporation Limited Class ASSE: 600161

Announcement on Subsidiary Obtaining Summary Report on Clinical Trial

· Issued by Beijing Tiantan Biological Products Corporation Limited Class A via Shanghai Stock Exchange
Announcement on Subsidiary Obtaining Summary Report on Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment